Quantcast
Last updated on April 21, 2014 at 9:24 EDT

Latest Paladin Stories

2014-04-15 08:30:33

Paladin Medical Products LLC, announces new patent pending enhancements to it's "Fairfield" style Evolution Equipment Rail and new Snap Action Adapters for optimum infection control support in clinical environments. OAKLAND, Fla., April 15, 2014 /PRNewswire/ -- Paladin Medical Products LLC. (Paladin) now offers an Anti-Microbial Finish (AMF) on all equipment, rail and head-wall products. Paladin has also embedded anti-microbial properties in its new lightweight plastic adapter,...

2014-02-26 12:26:21

MALVERN, Pa., Feb. 26, 2014 /PRNewswire/ -- Endo Health Solutions Inc. (NASDAQ: ENDP) ("Endo") today announced that, at the shareholder meeting held today, proposals related to Endo's proposed acquisition of Paladin Labs Inc. (TSX: PLB) ("Paladin") were approved by Endo's shareholders. As previously announced, on November 5, 2013, Endo and Paladin entered into an arrangement agreement pursuant to which each of Endo and Paladin will be acquired by a new Irish holding company, Endo...

2013-11-08 08:31:43

Independent financial education services provider helps people make better retirement decisions SACRAMENTO, Calif., Nov. 8, 2013 /PRNewswire/ -- Paladin Registry (www.PaladinRegistry.com) a leading provider of independent financial education and services for investors, announced the expansion of its content to include retirement planning and investing information. Paladin Registry has been featured in the Wall Street Journal, Forbes, Business Week, The Washington Post, The Chicago...

2013-11-05 08:33:20

MALVERN, Pa. and MONTREAL, Nov. 5, 2013 /PRNewswire/ -- -- Accelerates Endo's transformation to leading global specialty healthcare company and creates platform for future growth -- Paladin Labs' proven Canadian franchise, robust near-term pipeline and emerging market business complement Endo's U.S. strengths -- Combined company expects to grow presence in North America and internationally -- Stock and cash transaction values Paladin Labs at...

2013-09-18 08:36:13

SACRAMENTO, Calif., Sept. 18, 2013 /PRNewswire/ -- Paladin Research & Registry (www.PaladinRegistry.com) announced the launch of a powerful new online service that investors can use to check the quality of more than 260 financial advisor certifications and designations. Paladin's Check a Credential service is free and there is no registration requirement to use it. Jack Waymire, Paladin's founder, said: "Some financial advisors spend years acquiring high-quality credentials that...

2013-07-10 20:22:10

MISSISSAUGA, ON and MONTREAL, July 10, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, and Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company today announced that they have completed the amended loan arrangements (the "Loan") the details of which were previously announced on June...

2013-06-17 16:25:54

MISSISSAUGA, ON and MONTREAL, QC, June 17, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, and Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company today announced that they have amended their loan arrangements (the "Loan") originally agreed to in May 2012.  In May of 2012, Nuvo...

2013-06-05 20:23:44

BELLEVILLE, ON, June 5, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche") and Paladin Labs Inc.(TSX:  PLB) ("Paladin") today announced a comprehensive strategic collaboration to refinance and increase Bioniche's debt, provide new equity, and enter into the first licensing deal for Bioniche's Phase III bladder cancer product - Urocidin(TM). Debt Refinancing and Equity Paladin today acquired Bioniche's existing debt facility with Capital Royalty...

2012-10-09 19:21:19

SYDNEY and BEDMINSTER, N.J., Oct. 9, 2012 /PRNewswire/ -- QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a licensing agreement with Paladin Labs Inc. ("Paladin") (TSX:PLB) for the Canadian commercialisation rights to MOXDUO(®), a patented, immediate release formulation of morphine and oxycodone. Paladin is a leading Canadian specialty pharmaceutical company headquartered in Montreal, Canada, and is listed on the Toronto Stock Exchange. Paladin has working...

2012-08-15 06:27:08

SEATTLE, Aug. 15, 2012 /PRNewswire/ -- Roleplaying games as visual media just took a step closer to reality with the launch today of a new website for hobby game players around the world. Now roleplayers have the opportunity to experience a Dungeons & Dragons® campaign in a whole new way: through a Web series hosted exclusively at www.thefirstpaladin.com. Viewers can watch The First Paladin(TM), a campaign being played with D&D Next rules, and see the game evolve dynamically as...